Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,170
Closed -$225K 288
2020
Q2
$225K Buy
+1,170
New +$191K 0.02% 263
2019
Q1
Sell
-7,030
Closed -$801K 336
2018
Q4
$801K Buy
7,030
+3,700
+111% +$396K 0.07% 170
2018
Q3
$384K Buy
+3,330
New +$365K 0.03% 274
2014
Q1
Sell
-6,525
Closed -$307K 363
2013
Q4
$307K Sell
6,525
-25
-0.4% -$1.26K 0.03% 291
2013
Q3
$346K Buy
6,550
+650
+11% +$31.5K 0.04% 264
2013
Q2
$266K Buy
+5,900
New +$280K 0.03% 284

Other funds holding RMD

Bank of Hawaii's RMD Position: Q3 2020 in Review

Bank of Hawaii sold out of ResMed (RMD) in Q3 2020, closing a stake of 1,170 shares — an estimated $225K sold.

Bank of Hawaii first reported a position in RMD in Q2 2013 and held it in 6 quarters. The position peaked at $801K in Q4 2018. 627 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • Bank of Hawaii reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
  • Bank of Hawaii sold 1,170 ResMed shares in Q3 2020, an estimated $225K.
  • Bank of Hawaii first reported a position in ResMed in Q2 2013 and held it in 6 quarters.
  • Bank of Hawaii's ResMed position peaked at $801K in Q4 2018.
  • 627 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Bank of Hawaii's 13F filing for Q3 2020, filed 13 Nov 2020.